with little or no improvement in survival in phase III trials. In this article, the author describes the key studies presented at the Annual Meeting of ASCO, held in Atlanta
phase contrast imaging technique has been applied for the study of morphological variations in soft tissues. The effect of an antioxidant, α-lipoic acid in reducing hypercholesterolemia in rats ... Group II), positive…
half-cytotoxic concentration (CC50) > 100 μM; SI > 129. 87). A previous study in the US reported that remdesivir treatment demonstrated promising results. For evaluating the efficacy and safety of remdesivir…
progression compared with placebo. Data from the additional Phase III BRAVO trial are awaited with great interest. In all published studies, laquinimod was well tolerated and no severe side effects
cervical dilatation. Main outcome measures studied: 1. Duration of active phase of I stage, II stage and III stage. 2. Mode of delivery. 3. APGAR scores. 4. Untoward reactions
based cardiac rehabilitation (Home CR) programme using an individualized exercise (Physiotools-R) compared to phase III Hospital-based cardiac rehabilitation (Hospital CR) programme and standard care of Home…
environmental studies (1,2). New syntheses polystyrene polydimethyl siloxane polymer was loaded into the micropipette tip of the syringe system for solid phase microextraction of arsenic(III) and arsenic
this has led the antimalarial class to be studied as anticancer drugs in eight or more clinical trials, some in Phase III. We suspect that importance of eliminating
cells. In the Phase III placebo-controlled trial in relapsing–remitting multiple sclerosis (the CLARITY study), oral cladribine at 96 weeks significantly reduced annual relapse rates by 54–57% compared
activated protein kinase (MAPK) pathway. Preclinical and clinical studies demonstrated significant efficacy in differentiated thyroid cancer (DTC), and following the phase III DECISION trial comparing sorafenib to…
series of patients with advanced pancreatic cancer. This study provides efficacy and safety results similar to those of the pivotal phase III clinical trial that tested the same combination
encountered when survival is used as the primary study end point for evaluating the efficacy or effectiveness in phase II or III trials for advanced or metastatic cancer tumors
regular use of long-acting ß2-agonists (LABAs) with inhaled corticosteroids (ICSs), and some studies suggested patients with asthma who are homozygous for arginine (ArgArg) at the 16th amino acid ... those homozygous…
with few cases of disease progression. The Phase III randomized Evaluating Nilotinib Efficacy and Safety in Clinical Trials – newly diagnosed patients (ENESTnd) study results demonstrated higher cytogenetic and…
cases in Nepal. Methods: We conducted a multicenter, randomized (1:1), open labeled, phase III clinical trial among adults diagnosed with mild to moderate COVID-19 infections, as an inpatient ... outpatient basis…
weight heparin. The results of the Phase III Regulation of Coagulation in Major Orthopaedic Surgery Reducing the Risk of DVT and PE (RECORD) studies was that rivaroxaban was more effective
German phase 3 trial by Hofheinz et al showed that Capecitabine was equivalent to 5-FU. The primary objective of this study was to evaluate pathological response (PR), clinical & surgical ... outcomes of stage II & III…
treatment decision-making information for head and neck cancer patients. This cross-sectional study aimed to assess the impact of head and neck cancer and its treatment on the HRQoL ... those under pre-treatment phase…
clones. This article reviews the Phase I studies used to ascertain its safety profile, appropriate dosing and recommended scheduling. A Phase IIb/III trial compared afatinib with placebo in patients
targeted therapies. Although most of published studies are preliminary (phase I or phase II), they produced some promising results and therefore larger phase III trial can be justified
novel alpha emitter 223radium has been studied more extensively than other agents in this class and a recent large randomized phase III trial data with 223radium demonstrates overall survival benefit
III) in hippuric acid medium by using poly[dibenzo-18-crown-6] as stationary phase. The effect of hippuric acid concentration, different eluting agent, foreign ions etc. was studied ... optimum conditions were…
Considering a scalable implementation of EHR4CR solutions in up to 5-10% of Phase II, III and IV clinical trials to be commercially sponsored in Europe over 5 years ... current practices, the potential average 5-year…
Phase III clinical development for patients with severe uncontrolled asthma, is an investigational fully human monoclonal antibody designed to inhibit IL-13. In Phase II studies, tralokinumab improved lung function
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.